Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser , president and chief executive officer, will present at the Oppenheimer 31 st Annual Healthcare Conference
WARRINGTON, Pa., March 15, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (Formerly Known As Discovery Laboratories, Inc.) (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, president and chief executive officer, will present at the Oppenheimer 31st Annual Healthcare Conference and be available for 1x1 meetings. Details are as follows: Oppenheimer 31st Annual Healthcare Conference A live audio webcast will be available via the events page of the Windtree website at http://windtreetx.investorroom.com/events. A replay of the presentation will be archived on the Windtree website for 30 days for those unable to listen live. About Windtree Therapeutics For more information, please visit the Company’s website at www.windtreetx.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/windtree-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-301246440.html SOURCE Windtree Therapeutics, Inc. | ||
Company Codes: NASDAQ-NMS:WINT |